Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Source: www.nytimes.com ·
Section: politics ·
Bias: Center
· Published: Wed, 30 Sep 2026 17:48:55 GMT
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Read the full article at www.nytimes.com →
← Back to FlashTopics.com